FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:505-507 August 12, 1993 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Testa, M. A. PubMed Citation

To the Editor: Testa et al. (April 1 issue)¹ compared two antihypertensive medications, captopril and enalapril, with regard to their effects on quality of life in men. Patients treated with captopril had more favorable changes in overall quality of life, general perceived health, vitality, health status, sleep, and emotional control. The authors state that previous research had not employed sufficiently sensitive instruments or studied samples large enough to detect meaningful differences.

The findings of published studies of enalapril and quality of life^2,3,4,5 are not consistent with these conclusions. Steiner et al.² randomly assigned 360 men with hypertension to treatment with . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Bulpitt, C J, Fletcher, A E, Dössegger, L, Neiss, A, Nielsen, T, Viergutz, S (1998). Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Heart 79: 593-598 [Abstract] [Full Text]